Crimson staff writer

Ariel H. Kim

Crimson staff writer Ariel H. Kim can be reached at ariel.kim@thecrimson.com.

Latest Content


Experts Across Disciplines Tackle Racism within Health Care During Virtual Panel

The conversation — moderated by Michelle Morse, assistant professor at Harvard Medical School — was part of the Health Policy and Bioethics Consortia, a monthly series organized by the Medical School and the Law School that brings together experts from separate disciplines to discuss issues relating to biomedical innovation and healthcare delivery.


Reparations for Slavery Could Have Mitigated U.S. Covid Infections, HMS Study Finds

Reparations for descendants of enslaved individuals in the U.S. could have reduced Covid-19 transmission among Black Americans, according to a peer-reviewed study published online last Tuesday by Harvard Medical School researchers.


Journal Delays Print Publication of Harvard Law Professor’s Controversial ‘Comfort Women’ Article Amid Outcry

The International Review of Law and Economics told The Crimson Friday it will temporarily delay print publication of Harvard Law professor J. Mark Ramseyer’s controversial paper, which claims sex slaves in Imperial Japan, known as “comfort women,” were voluntarily employed.


Harvard Professor’s Paper Claiming ‘Comfort Women’ in Imperial Japan Were Voluntarily Employed Stokes International Controversy

A paper by Harvard Law School Japanese legal studies professor J. Mark Ramseyer that claims sex slaves taken by the Imperial Japanese Army during World War II were actually recruited, contracted sex workers generated international controversy, academic criticism, and student petitions at Harvard this week.


Johnson & Johnson Files for Emergency Use Authorization of Covid-19 Vaccine Developed With Beth Israel

Johnson & Johnson filed for emergency use authorization Thursday for its newly-created Covid-19 vaccine — developed with researchers at Beth Israel Deaconess Medical Center, a teaching hospital affiliated with Harvard Medical School — after announcing results from its phase three clinical trials last Friday.


Harvard Researchers Find Mothers Rarely Pass on the COVID-19 Virus or Antibodies to Newborns

Pregnant women infected with SARS-CoV-2 during their third trimester are unlikely to pass on the virus or protective antibodies to their newborn, according to two studies by Harvard Medical School researchers published last month.